Article Image
Radio/TV • Declare Your Independence with Ernest Hancock
Program Date:

06-12-19 -- Alessandro Fusillo - Paul Rosenberg - Dr Judy Mikovits, PhD (VIDEO's & MP3s LOADED)

Alessandro Fusillo (Libertarian Attorney in Italy, Germany) on Brexit, Italy and the EU; Is Italy Poised to Launch Euro Parallel Currency? - Dr Judy Mikovits (PhD, Molecular Biology) on her fight and focus to stop vaccine mandates (Especially SB276
Media Type: Audio • Time: 174 Minutes and 0 Secs
Guests: Alessandro Fusillo, ,
Media Type: Audio • Time: 59 Minutes and 43 Secs
Guests: Paul Rosenberg, ,
Media Type: Audio • Time: 54 Minutes and 30 Secs
Topics: Vaccines

Hour 1 - 3

Media Type: Audio • Time: 174 Minutes and 0 Secs
Guests: Alessandro Fusillo, ,

Broadcast Date: June 12th, 2019

Live Broadcasts:

DLive

Twitch

YouTube

Archived Videos:

YouTube.Com - Ernest Hancock

IPFS:

Freedom's Phoenix - https://ipfs.io/ipns/QmW6iyZ27fYAwd15CQ9nDkLhZPa5QsfbZ8EuSoncHgwA8Y/

Pirates without Borders - https://ipfs.io/ipns/QmTHfBRjU826uZxDvwfV9ZzM7pCg71bMYVTgLFVvsZZwPJ/

The Corbett Report - https://ipfs.io/ipns/QmNqHuSVuufkBKK1LHtoUmKETobZriC1o5uoiXSoLX2i3K/

 

Hour 1 - Alessandro Fusillo (Libertarian Attorney in Italy, Germany) on Brexit, Italy and the EU; Is Italy Poised to Launch Euro Parallel Currency?

Hour 2 - Paul Rosenberg comes on the show to discuss the re-naming of his subscriber-based newsletter to Parallel Society, providing a more outward focus and his hope for the future...Paul discusses his latest issue: Tradecraft, Part Two...

Hour 3 - Dr Judy Mikovits (PhD, Molecular Biology) on her fight and focus to stop vaccine mandates (Especially SB276 in CA)

 

CALL IN TO SHOW: 602-264-2800

-30-

Letters of Marque Paperback

AVAILABLE ON AMAZON NOW BY CLICKING HERE!

Letters of Marque Paperback – September 25, 2018

by Marque dePlume (Author)

"The Crown calls it 'piracy' to explore frontiers beyond its grasp. So the time has come to define the conduct among pirates." Captain Marque

http://pirateswithoutborders.com/

Join us 'Above the Grid'

================================

 

 

Hour 1

Alessandro Fusillo

Alessandro Fusillo is an attorney in Italy, Germany and Spain and is fluent in five languages. Due to the socialist indoctrination of European schools and universities he joined Austrian Economics and Libertarian Philosophy only in his mature years. As an attorney specialized in commercial and tax law, he often represents clients against the State and banksters. Faithful to the Jeffersonian principle that when law becomes injustice resistance becomes a duty, he always strives to undermine as much as possible the multiple laws whose only aim is to encroach the freedom.

Libertarian Attorney (Italy, Germany)

Alessandro provides information and thoughts on Brexit, Italy, EU, etc...

 

Webpage: http://www.studiolegalefusillo.com/

==================================

Alessandro's previous interviews on the Declare Your Independence with Ernest Hancock Radio Show:

https://www.freedomsphoenix.com/Guest-Page.htm?No=00995

==================================

TOPICS DISCUSSED...

Brace for Impact: Italy Poised to Launch Euro Parallel Currency

https://moneymaven.io/mishtalk/economics/brace-for-impact-italy-poised-to-launch-euro-parallel-currency-jfYIUXnEmUe-yeo0-uVZrg/

Mish

by7 days-edited

Italy faces an "Excessive Deficit" ruling, the first in EU history. Italy's response is a parallel currency proposal.

A euro crisis has been brewing for years.

Eurozone officials and the ECB have long held the upper hand vs individual countries like Greece and Portugal.

However, Italy now has the upper hand, if it chooses to wage war.

Let's backup and start from the beginning to tie this story together.

Excessive Debt

Please consider EU Could Slap 3 Billion Euro Fine on Italy for Excessive Debt.

The European Commission could impose a 3 billion euro fine on Italy for breaking EU rules due to its rising debt and structural deficit levels, the country's Deputy Prime Minister Matteo Salvini said on Tuesday.

Salvini, whose far-right League party triumphed in European elections on Sunday, said he would use "all my energies" to fight what he said were outdated and unfair European fiscal rules.

"Let's see if we get this letter where they give us a fine for debt accumulated over the past and tell us to pay 3 billion euros," Salvini said in an interview with RTL radio.

What About France?

Daniel Lacalle on Twitter

Daniel Lacalle on Twitter

"While everyone is talking about Italy and its budget deficit, France has not had a balanced budget since the late 70s,"

twitter.com

?

France vs Italy Key Points

The current debate is over excessive debt, not deficits.

Italy is in defiance of debt, not deficit rules, but its proposed budget will violate both.

France violates both sets of numbers already, but not by as much.

In essence, there is one set of rules for France and Germany and another set of rules for everyone else.

Parallel Currency Proposal

Please consider Italy to Activate its 'Parallel Currency' in Defiant Riposte to EU Ultimatum.

"I don't govern a country on its knees," said Matteo Salvini after sweeping the European elections even more emphatically than the Brexit party. Note the majestic 'I'. He is already master of Rome.

The Lega strongman can no longer be contained, even by Italy's ever-ingenious mandarin class. His party commands 40pc of the country together with eurosceptic confederates from the Brothers of Italy. It has erupted like a volcano in the Bourbon territories of the Mezzogiorno, now on the front line of migrant flows and left to fend for itself by Europe. Salvini can force a snap-election at any time.

By some maniacal reflex the dying Commission of Jean-Claude Juncker has chosen this moment to draw up the first indictment letter of the revamped debt and deficits regime. Italy faces €3.5bn of fines for failure to tighten its belt. It has 48 hours to respond.

"We're not Greece," said Claudio Borghi, Lega chairman of Italy's house budget committee. "We are net contributors to the EU budget. We have a trade surplus and primary budget surplus. We don't need anything from anybody. And we are in better shape than France."

"I am not going to hang myself for some silly rule," said Salvini. "Until unemployment falls to 5pc we have a right to invest. We have regions where youth unemployment is 50pc. We need a Trump cure, a positive fiscal shock to reboot the country." His plan is a €30bn boost led by a flat tax of 15pc.

Concerns Over "Euro Default Risk" Mount

The concerns over Italy have hit mainstream media in the EU, but not the US. For example, please consider German Bundesbank Comes Clean on Euro Default Risks After Italy's 'Parallel Currency' Decree

The German Bundesbank has warned that it could face heavy losses if a major country leaves the euro and defaults on debts to the European Central Bank system, but warned that any attempt to prepare for such a crisis could backfire by triggering a speculative attack.

The analysis is highly sensitive coming just days after the insurgent Lega-Five Star government in Italy passed a decree in the Italian parliament authorizing the creation of a parallel payments system known as 'minibots', a scheme decried by critics as a threat to the integrity of the euro and potentially a 'lira-in-waiting'.

While the Bundesbank text sticks to the standard line that a euro break-up is hypothetical it nevertheless admits - after years of obfuscation - that the ECB's internal Target2 settlement system entails inescapable costs for Germany and other EMU member states should it ever happen. It also gives the impression that the monetary authorities have no clear strategy for handling such a crisis.

Professor Philip Turner, a former monetary official at the Bank for International Settlements, said the politics of Target2 are poisonous. "This is lending on a huge scale that no government has approved. It is covering fundamental imbalances at the heart of the eurozone system, and it can't go on indefinitely," he said.

The International Monetary Fund says it would be hard to prevent a sovereign debt crisis in Italy engulfing Spain and Portugal. The ECB could therefore face a Target2 crisis approaching €1 trillion if Italy's rebel government sets off a chain reaction with its 'minibot' notes - which it claims are needed to cover €52bn of state arrears to Italian contractors and households.

The Bundesbank's text states that if a country leaves EMU and its central bank defaults on Target2 liabilities, the ECB will have to eat through a series of buffers: first its own capital - dramatic enough - and then by drawing in money from the remaining central banks on a 'capital key' basis.

Not Shocking

There is not a single thing shocking in the preceding analysis other than the discussion is finally taking place at top levels.

I have been discussing Target2 imbalances for years.

Eight Reasons a Financial Crisis is Coming

"One Size Fits Germany" Math Impossibility, Get Your Money Out of Italy Now!

Eurointelligence Displays Stunning Ignorance Regarding Target2

Another Rebuttal to the Idea that Target2 Claims are "Fictional"

Masters in Circumventing Rules

About one year ago, I commented a Reader From Italy Chimes in on the "Minibot" Parallel Currency Idea.

Hello Mish

Regardless of anything else: Italians are masters in finding smart ways to circumvent rules. There is even an adage in Italy regarding this.

On that basis, I would not be surprised if at one point in time, someone in Brussels or Frankfurt will realize too late precisely what is happening. .....

This was my reply to reader "AC":

Germany gets to decide between debt mutualization or a breakup of the Eurozone and Italian default on Target2 imbalances. The only other possibility that comes to mind is the ECB prints enough to backstop Target2.

Target2 Imbalances April 2019

Italy, Spain, Germany

Italy owes creditors, primarily Germany, €481 billion.

Spain owes creditors, primarily Germany, €403 billion.

Germany needs to collate €919 billion from debtors.

The above numbers have not changed that much in the past year.

What Has Recently Changed?

The answer is amusing.

To prevent Beppe Grillo and his 5-Star movement from coming into power, Italy changed its election rules to give coalitions more power than parties.

The result is Salvini might win so much support in the next election that he may have a super-majority in Parliament so as to not need a referendum to launch the mini-bot parallel currency.

And so, here we are.

Italy owes creditors close to half a trillion euros. If Italy defaults, the rest of the countries have to pick up the tab based on GDP percentage weights.

Default Percentages

Curiously, via ESM Rules, if Italy were to default, Italy would be responsible for 17.91% of the tab.

Germany would be liable for 27.14% of the tab.

Spain, which already has a Target2 liability of €403 billion would be responsible, in theory, for picking up 11.9% of €481 billion, but that doers not count the 17.9% that Italy would of course not pay.

Upper Hand?

With Greece and Portugal, the ECB had the upper hand.

Who has the upper hand here?

I suggest Italy and I hope Italy uses it.

Mike "Mish" Shedlock


Hour 2

Media Type: Audio • Time: 59 Minutes and 43 Secs
Guests: Paul Rosenberg, ,

Hour 2 - Paul Rosenberg comes on the show to discuss the re-naming of his subscriber-based newsletter to Parallel Society, providing a more outward focus and his hope for the future...Paul discusses his latest issue: Tradecraft, Part Two...

-30-

Letters of Marque Paperback

AVAILABLE ON AMAZON NOW BY CLICKING HERE!

Letters of Marque Paperback – September 25, 2018

by Marque dePlume (Author)

"The Crown calls it 'piracy' to explore frontiers beyond its grasp. So the time has come to define the conduct among pirates." Captain Marque

http://pirateswithoutborders.com/

Join us 'Above the Grid'

================================

Hour 2

Paul Rosengerg

Freeman's Perspective

Webpages:

http://www.freemansperspective.com/

https://secure.cryptohippie.com/

Paul Rosenberg knows a lot about a lot of things. A lifestyle capitalist with a broad range of interests and experiences under his belt, current passions include philosophy, theology, history, psychology, and physics. This diverse interest base is reflected in his extensive repertoire of published titles, including A Lodging of Wayfaring MenThe Words of the Founders, and Production Versus Plunder, not to mention 55 engineering and construction books.

Prior to this, his highly successful engineering career saw him called as an expert witness in numerous legal cases and recruited as a consultant to a number of high profile organizations, such as NASA and the US military. He developed and taught 19 continuing education courses for Iowa State University's College of Engineering. He also co-founded the Fiber Optic Association and wrote the first ever standard for the installation of fiber optic cables.

Paul Rosenberg has been featured on or at:

Project To Restore America

LewRockwell.com

Casey Research

Zero Hedge

RT

QWealth

The Daily Paul

Early to Rise

Story Leak

Expat World

International Man

Strike-The-Root.com

The Burning Platform

Global Wealth Protection

Freedom Fest

Libertopia

Freedom's Phoenix

==============================

 

Paul's previous interviews on the Declare Your Independence with Ernest Hancock Radio Show:

https://www.freedomsphoenix.com/Guest-Page.htm?No=00913

==========================

Paul comes on the show to discuss the re-naming of his subscriber-based newsletter to Parallel Society, providing a more outward focus and his hope for the future...Paul discusses his latest issue: Tradecraft, Part Two...

 


Hour 3

Media Type: Audio • Time: 54 Minutes and 30 Secs
Topics: Vaccines

Hour 3 - Dr Judy Mikovits (PhD, Molecular Biology) recap Autism One Conference and Arizona March for Medical Freedom; Update on Forced Vaccinations

-30-

Letters of Marque Paperback

AVAILABLE ON AMAZON NOW BY CLICKING HERE!

Letters of Marque Paperback – September 25, 2018

by Marque dePlume (Author)

"The Crown calls it 'piracy' to explore frontiers beyond its grasp. So the time has come to define the conduct among pirates." Captain Marque

http://pirateswithoutborders.com/

Join us 'Above the Grid'

================================

Hour 3

Dr. Judy Mikovits, PhD

To contact Judy: marcinc0224@gmail.com

Webpage: http://www.marcinc.org/

(UPDATE - THE MARCINC.ORG WEBSITE HAS BEEN HACKED. PLEASE USE http://www.plaguethebook.com/)

Judy testified on a lawsuit for Racketeering and conspiracy against the CA legislators who passed the SB277 mandating toxins be inoculated in their children under the guise of vaccination and she will re-cap her testimony...

Lawsuit: 

First-Amended-RICO-Complaint--img20160817_09071194.pdf

 

Other references and webpages:

http://www.plaguethebook.com/

http://vaxtruth.org/

http://www.truthrx.org/

Judy's previous interviews on the Declare Your Independence with Ernest Hancock Radio Show:

 https://www.freedomsphoenix.com/Guest-Page.htm?No=01359

Judy A. Mikovits, PhD has spent her life training to be a research scientist to honor her grandfather who died of cancer when she was a teenager. Dr. Mikovits earned her BA from University of Virginia and PhD in Biochemistry and Molecular Biology from George Washington University. In her 35-year quest to understand and treat chronic diseases, she has studied immunology, natural products chemistry, epigenetics, virology and drug development. In just over twenty years she rose from an entry-level lab technician to become director of the lab of Antiviral Drug Mechanisms at the National Cancer Institute before leaving to direct the Cancer Biology program at EpiGenX Pharmaceuticals in Santa Barbara, California where she had met and married David Nolde in 2000. There in 2006, she became attracted to the plight of patients with Chronic Fatigue Syndrome and Autism. In only five years she developed the first neuroimmune institute from a concept to a reality and is primarily responsible for demonstrating the relationship between immune based inflammation and these diseases. She has published over 50 scientific papers.

Dr. Judy A. Mikovits recently founded MAR Consulting Inc. with her collaborator Dr. Frank Ruscetti. 

=======================================

TOPICS TO BE DISCUSSED ON THE SHOW...

1.

Dr Judy's upcoming book (to be release November 5th, 2019) can be pre-ordered on Amazon (https://www.amazon.com/dp/B07S5H6T4Q)

 

2. Vaccine Rhetoric vs. Reality—Keeping Vaccination's Unflattering Track Record Secret

https://childrenshealthdefense.org/news/vaccine-rhetoric-vs-reality-keeping-vaccinations-unflattering-track-record-secret/?utm_source=mailchimp

June 11, 2019

By the Children's Health Defense Team

[Note: This is Part VI in a series of articles adapted from the second Children's Health Defense eBook: Conflicts of Interest Undermine Children's Health. The first eBook, The Sickest Generation: The Facts Behind the Children's Health Crisis and Why It Needs to End, described how children's health began to worsen dramatically in the late 1980s following fateful changes in the childhood vaccine schedule.]

A concerted and "heavy-handed" effort is under way to censor information that contradicts the oversimplified sound bites put forth by public health agencies and the media about vaccines. However, while brazen, in-your-face censorship—and attacks on health freedom—have ratcheted up to an unprecedented degree,  officialdom's wish to keep vaccination's unflattering track record out of the public eye is nothing new.

There is a chasm between vaccine rhetoric and reality for most if not all vaccines, but four vaccines—varicella (chickenpox), rotavirus, human papillomavirus (HPV) and pertussis-containing vaccines—offer especially instructive before-and-after case studies. Analysis of the U.S. experience with these vaccines raises important questions. First, why did the Food and Drug Administration (FDA) race to approve—and why does the Centers for Disease Control and Prevention (CDC) heavily promote—vaccines such as varicella and rotavirus when there is little public health justification for them? Second, why are federal agencies ignoring the many serious risks that have surfaced in the vaccines' wake—problems unheard of before the vaccines' introduction?

With the rollout of mass varicella vaccination, shingles started cropping up to an unprecedented extent in both children and adults, eliminating boosting for adults and shifting downward the average age at which shingles occurs.

Varicella and rotavirus vaccines

The rationale for the varicella and rotavirus vaccines was dubious from the start. In the U.S. and other wealthy countries, varicella and rotavirus were nearly universal and mostly benign childhood infections; in those settings, the pre-vaccine impact of the two conditions was largely measured in terms of "healthcare costs, missed daycare, and loss of time from work for parents/guardians" rather than in terms of serious illness or mortality.

Childhood chickenpox infections served an important purpose for all, conferring lifelong immunity to infected children while boosting adult immunity to the related shingles (herpes zoster) virus. With the rollout of mass varicella vaccination, shingles started cropping up to an unprecedented extent in both children and adults, eliminating boosting for adults and shifting downward the average age at which shingles occurs. Vaccine waning also began increasing young adults' risk for varicella outbreaks and complications later in life, presenting "perverse public health implications." Meanwhile, the CDC and its local public health partners worked hard to conceal these unwanted chickenpox vaccine outcomes from the public.

Rotavirus vaccines have had a similarly checkered history. Soon after their introduction in the U.S., reports emerged of a substantially increased risk in infants of an otherwise rare bowel complication called intussusception. The FDA knew about the problem during the prelicensing regulatory review process but ignored it. Although the agency subsequently withdrew its approval for one of the problematic rotavirus vaccines, it was not until after an estimated 500,000 children received at least one million doses. The FDA never explained the "precise mechanism" by which the discontinued vaccine caused intussusception.

Two rotavirus vaccines that display the same intussusception risks are still on the U.S. market. Both are contaminated with foreign DNA from porcine viruses capable of causing severe immunodeficiency in pigs. Had the presence of these "adventitious agents" been discovered prior to vaccine licensure, the FDA probably would have been forced to shelve the vaccines, yet they remain on the vaccine schedule to this day.

The speed with which the FDA gave them [HPV vaccines Gardasil and Gardasil-9] the go-ahead—despite obvious red flags regarding their safety—illustrates the insincerity of the agency's assertions that its vaccine approval process is committed to minimizing risks.

HPV vaccines

The HPV vaccines Gardasil and Gardasil-9 (manufactured by Merck) represent perhaps an even more compelling case study of risk-laden vaccines that should have attracted strong up-front regulatory scrutiny—but didn't. The speed with which the FDA gave them the go-ahead—despite obvious red flags regarding their safety—illustrates the insincerity of the agency's assertions that its vaccine approval process is committed to minimizing risks.

The FDA not only gave the quadrivalent Gardasil a free pass but has repeatedly reapproved it and the nine-valent Gardasil-9 for wider use. (Gardasil-9 is a newer formulation that contains more than twice the amount of neurotoxic aluminum adjuvant as Gardasil.) In 2009, the FDA also okayed GlaxoSmithKline's HPV vaccine, Cervarix, but Merck's FDA-facilitated stranglehold on the market prompted the company to withdraw Cervarix from the U.S. in 2016. Merck is now aggressively expanding its Gardasil "franchise" into other countries, generating unprecedented worldwide demand, while continuing to "rev up" U.S. sales.

Since 2006, the FDA's Gardasil-related decisions have included:

2006: Granting fast-tracked approval for the original quadrivalent Gardasil vaccine (girls and women aged 9 to 26 years)

2009: Approving Gardasil's use in boys and men (ages 9-26)

2014: Approving Gardasil-9 (girls ages 9-26, boys ages 9-15)

2015: Approving Gardasil-9 for boys ages 16-26

2018: Approving Gardasil-9 for older women and men (ages 27-45)

An eight-month investigation by Slate identified numerous troubling aspects of the clinical trials that encouraged U.S. and European regulators to approve Gardasil. The Slate reporter also criticized regulators for allowing "unreliable methods to be used to test the vaccine's safety." These included Merck's use of "a convoluted method" that made it difficult to objectively evaluate and report side effects; its failure to document "symptom severity, duration, outcome, or overall seriousness"; restriction of adverse event reporting to just 14 days following each injection; and reliance on the subjective opinion of clinical trial investigators regarding "whether or not to report any medical problem as an adverse event." Not infrequently, clinical trial participants who shared complaints of debilitating symptoms with trial investigators were dismissed with the response, "This is not the kind of side effects we see with this vaccine."

The author of the Slate investigation reported:

Experts I talked to were baffled by the way Merck handled safety data in its trials. According to…a professor…who studies side effects, letting investigators judge whether adverse events should be reported is "not a very safe method of doing things, because it allows bias to creep in." …Of the short follow-up…,"It's not going to pick up serious long-term issues, which is a pity. Presumably, the regulators believe that the vaccine is so safe that they don't need to worry beyond 14 days."

Two years after Gardasil's initial approval, Judicial Watch pronounced it a "large-scale public health experiment." Post-licensure studies carried out since then confirm that HPV vaccines have grave risks, including impaired fertility, demyelinating disease, chronic limb pain, circulatory abnormalities and autoimmune illness, to name just some of the disabilities reported in the aftermath of HPV vaccines' introduction. Overall, the "rate of reported serious adverse reactions (including deaths) from HPV vaccination" is many times higher than the cervical cancer mortality rate.

Recent data suggest that HPV vaccines may be increasing cervical cancer risks.

In a February 2019 letter to the CDC, Children's Health Defense Chairman Robert F. Kennedy, Jr. noted, "During Gardasil's clinical trials, an extraordinary 49.5% of the subjects receiving Gardasil reported serious medical conditions within seven months of the start of the clinical trials. Because Merck did not use a true placebo in its clinical trials, its researchers were able to dismiss these injuries as sad coincidences." A current civil case brought on behalf of a 24-year-old who has suffered from systemic autoimmune dysregulation since receiving her third Gardasil vaccine at age 16 alleges that Merck "committed fraud during its clinical trials and then failed to warn [vaccine recipients] about the high risks and meager benefits of the vaccine." The trial's legal team is benefiting from the support of an "A-team" of plaintiffs' law firms and attorneys, including Kennedy, Jr.

Recent data suggest that HPV vaccines may be increasing cervical cancer risks. A 2017 study out of Australia—which has heavily promoted routine HPV vaccination since 2007—reported an increased risk of difficult-to-detect malignant cervical lesions among the HPV-vaccinated. In all countries where HPV vaccination coverage is high, including Australia, official cancer registries show "an increase in the incidence of invasive cervical cancer" in the vaccinated age groups. In England, "2016 national statistics showed a worrying and substantial increase in the rate of cervical cancer…at ages 20-24"—the first HPV-vaccinated cohort.

The proper decision would be to take HPV vaccines off the market, but the FDA and CDC continue to look the other way. Both agencies' unwavering support for Gardasil has clearly helped Merck's commercial bottom line, so much so that the CDC director at the time of Gardasil's approval (Julie Gerberding) went on to be appointed president of Merck's profitable vaccine division (worth $5 billion globally) in 2009. The agencies' willingness to aggressively promote HPV vaccination despite its readily apparent dangers illustrates a "public health flimflam" of the first order. Before the U.S. introduction of HPV vaccination, a decades-long pattern of declining cervical cancer rates was already well underway, thanks to routine cervical cancer screening. HPV vaccines have never even been proven to prevent cervical cancer. In 2016, researchers admitted that they would be unable to ascertain HPV vaccines' long-term efficacy for "at least another 15-20 years."

Officials also seem to have little interest in modern evidence documenting many vaccines' inability to provide the promised protection, even when vaccine coverage is widespread.

Pertussis-containing vaccines

Alongside their many misplaced claims about various vaccines' rationale and safety record, the FDA and CDC—as echo chambers for the vaccine industry—also have misinformed the public about vaccine effectiveness. Back in 1899, doctor William Bailey (vaccination enthusiast and member of the State Board of Health in Louisville, Kentucky) was more honest, cautioning that "nothing is gained by claiming too much" about vaccine-induced immunity and stating that "the degree of immunity may vary with time and circumstance"—presaging the troublesome modern phenomena of vaccine failure and waning immunity. In the present day, officials are only too willing to "claim too much," conveniently ignoring historical evidence that reductions in infectious disease had little to do with vaccines and far more to do with improvements in sanitation and nutrition. Officials also seem to have little interest in modern evidence documenting many vaccines' inability to provide the promised protection, even when vaccine coverage is widespread.

The acellular version of pertussis (whooping cough)—a component of U.S. vaccines such as DTaP and Tdap—is one of the vaccines noted for its abysmal effectiveness. The vaccine is supposed to protect against the respiratory infection caused by Bordetella pertussis. Instead, according to recent studies, pertussis is making a "surprising" comeback; between 1990 and 2005, pertussis epidemics increased in the U.S. "in both size and frequency," and over half of all cases occurred in highly vaccinated adolescents aged 10 to 20 years old. In fact, not only is pertussis at its highest level since the mid-1950s, but, according to CDC researchers, it is showing signs of being vaccine-resistant. The CDC researchers also note "substantial heterogeneity among vaccine recipients in terms of the durability of the protection they receive."

… the researchers concluded in 2017 that all currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis …

West Africa has used the DTP vaccine since the 1980s—formulated with a whole-cell pertussis component instead of acellular pertussis—and it has an even more horrifying safety and effectiveness record than its acellular counterparts. Research published in 2017 by a prestigious team of international scientists and led by vaccinology expert Dr. Peter Aaby found that DTP vaccination had a negative effect on child survival, with fivefold higher mortality in young DTP-vaccinated infants (ages three to five months) compared to as-yet-unvaccinated infants. When the researchers published results in 2018 for slightly older DTP-vaccinated children (ages six months to three years), they continued to observe more than double the risk of death as similarly situated unvaccinated children. Explaining that vaccines can increase susceptibility to other infections, the researchers concluded in 2017 that "all currently available evidence suggests that DTP vaccine may kill more children from other causes than it saves from diphtheria, tetanus or pertussis" and added in 2018 that "all studies of the introduction of DTP have found increased overall mortality."

Learning from history

Efforts to counter the official vaccine narrative with evidence about negative consequences date back to the days of smallpox. A doctor practicing in the 1870s observed that smallpox mortality doubled (from roughly 7% to 15%) after adoption of smallpox vaccination. During an outbreak in 1871 and 1872, this doctor stated, faith in vaccination received a "rude…shock" when "[e]very country in Europe was invaded with a severity greater than had ever been witnessed during the three preceding centuries." The doctor also noted that "many vaccinated persons in almost every place were attacked by small-pox before any unvaccinated persons took the disease." In this individual's estimation, these facts were "sufficient to overthrow the entire theory of the protective efficacy of vaccination."

In the present era, federal agencies continue to tout difficult-to-justify but money-spinning vaccines as beneficial, even in the face of substantial evidence to the contrary. Now, more than ever, it is important to illuminate the risks and downsides that public health agencies do not want us to know about.

Watch Streaming Broadcast Live:

Watch the Ernest Hancock Show on DLive
DLive
Watch the Ernest Hancock Show on LRN.fm
LRN.fm
Live Chat
Talk about the Ernest Hancock Show on Telegram
Telegram
Listen to the Ernest Hancock Show
LRN.fm
Live Phone:
641-793-8869
 

Apple Podcast

Please help fund Declare Your Independence with a one-time or recurring donation.


Archive By Year


Shows By Topic

Shows By Guest


thelibertyadvisor.com/declare